about bpl

Bio Products Laboratory Ltd.

BPL announces new vial size for Gammaplex®

Date added: Tuesday 25th March 2014
Latest updated: Wednesday 8th February 2017

BPL is pleased to announce that the MHRA has now approved a 20 g vial size for Gammaplex, BPL's intravenous immunoglobulin preparation.  The new 20 g vial size will offer users improved choice and convenience as fewer vial changes will be needed when 20 g or more Gammaplex are infused.  The new vial size can also save valuable storage space compared with two 10 g vials.

Gammaplex is approved in UK for primary, secondary immunodeficiency, immune thrombocytopenic purpura (ITP) and Guillain Barre syndrome. Gammaplex will be offered in 5 g, 10 g and 20 g vial sizes and is now available to order.

 

 UK/Gx/0314/0006, Date of Preparation:  March 2014

Patient information leaflets